Vaccines

Jorge Carrasco, president of the Chilean Society of Pediatrics, said flu vaccine coverage for children under five stands at only 60.54%, below the 80% target.

2026년 05월 22일 AI에 의해 보고됨

Australia has recorded 230 cases of diphtheria and one related death this year. The outbreak is concentrated in remote Indigenous communities across several states.

Researchers led by Flinders University have identified the molecular trigger behind a rare blood clotting disorder linked to adenovirus-based COVID-19 vaccines and infections. The immune system mistakes an adenovirus protein for the human blood protein PF4, leading to harmful antibodies in extremely rare cases. The discovery, detailed in the New England Journal of Medicine, paves the way for safer vaccines.

2026년 04월 04일 AI에 의해 보고됨

Small-scale farmers in South Africa's Eastern Cape have voiced frustration over inaccessible foot-and-mouth disease (FMD) vaccines, saying they have sought help from the Department of Agriculture without success.

Researchers at Northwestern University have developed a more effective therapeutic vaccine for HPV-related cancers by rearranging components in a DNA-based nanoparticle. This structural adjustment significantly enhances the immune system's ability to target and destroy tumors. The findings, published in Science Advances, highlight the importance of molecular arrangement in vaccine design.

2026년 02월 16일 AI에 의해 보고됨

In a recent meeting with the Cuban president, health experts presented progress on the Finlay Vaccine Institute's pneumococcal conjugate vaccine development program. This effort, led for over 20 years, aims to protect children and older adults from severe diseases caused by Streptococcus pneumoniae. The heptavalent Quimi-Vio® vaccine is already registered and shows positive results in reducing mortality.